Answers are grounded in this paper and cite their sources.
Ventilator associated pneumonia (VAP) leads to an increase in morbidity, mortality, and healthcare costs. In addition to increased evidence from the latest European and American guidelines (published in 2017 and 2022, respectively), in the last two years, several important clinical experiences have added new prevention tools to be included to improve the management of VAP.
No takes yet. Share an insight, caveat, or question.
Lorente et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: